3 results
ObjectivesPrimary* To determine the efficacy (as assessed by radiographic progression free survival [rPFS]) of AZD4635 plus durvalumab and separately of AZD4635 plus durvalumab plus cabazitaxel in participants with mCRPC.Secondary* To evaluate the…
Primary Objective:Evaluating the predictive value of CAUS to assess the steatosis severity, combining multiple CAUS parameters (RAC, LAT, SNR, MU, AX), with 1H-MRS as a reference in adult patients with CIF.Secondary Objective(s):-To assess the…
The purpose of this study is to determine if the combination of relatlimab and nivolumab improves overall survival (OS) in all randomized participants and participants with PD-L1 CPS >= 1 with later-line metastatic colorectal cancer compared…